Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06645847 · ClinicalTrials.gov registry record · NA

Targeting Aging With a Ketone Ester for Function in Frailty

A NA study of Aging and Frail Elderly, sponsored by Buck Institute for Research on Aging.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
3
Study locations

NCT06645847: Recruiting NA study of Aging and Frail Elderly, sponsored by Buck Institute for Research on Aging.

NCT06645847 is a NA study of Aging and Frail Elderly that is actively recruiting participants, run by Buck Institute for Research on Aging. The registered enrollment target is 180 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06645847, a NA study of Aging and Frail Elderly, is actively recruiting participants, sponsored by Buck Institute for Research on Aging.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
3
Study locations

Study Summary

This study aims to find out if a food supplement that contains a naturally occurring substance, ketones, can help to improve strength and general wellness in adults at, or over the age of 65 years who are experiencing a slight decline in their physical function. Participation will involve a screening visit and 4 additional study visits over the course of 20 weeks. After being assessed for eligibility, study participants will be sorted into two groups at random and consume either a ketone or placebo supplement at home every day for 20 weeks. Both study products can cause gastro-intestinal side effects in some individuals. At all study visits, subjects will provide blood samples. At three study visits, subjects will be asked to complete physical performance tests, provide blood, stool and urine samples. They will also complete questionnaires during three study visits to assess physical function, markers of inflammation, and other aspects of general well-being. The study enrolls at three sites across the United States, in California (Buck Institute), Ohio (Ohio State University), and Connecticut (University of Connecticut). The study is coordinated by the San Francisco Coordinating Center (California Pacific Medical Center).

Primary Outcome

The primary outcome measure is the difference in the change in a four-item composite score of vigor-frailty (6 minute walk, 1 rep max leg press, digit symbol substitution, Pittsburg Fatigability Scale - Physical sub scale) over 20 weeks between groups. The original composite score was developed by the Study of Muscle Mass and Aging Group, it is continuous, and a higher score corresponds to better function.

Interventions

  • OTHER Ketone ester
  • OTHER Placebo Comparator: Non-ketone placebo

Study Locations (3)

California

  • Buck Institute for Research on Aging - Novato

Connecticut

  • UConn Health - Farmington

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2025-02-05
Est. Completion 2028-04-01
Phase NA

What NCT06645847 shows while recruiting

NCT06645847 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Ketone ester is the first listed.

NCT06645847 reports a single indexed study location in California, Connecticut, Ohio.

Frequently Asked Questions

What is clinical trial NCT06645847 about?

NCT06645847 is a clinical study titled "Targeting Aging With a Ketone Ester for Function in Frailty". This study aims to find out if a food supplement that contains a naturally occurring substance, ketones, can help to improve strength and general wellness in adults at, or over the age of 65 years who are experiencing a slight decline in their physical function. Participation will involve a screeni...

What is the current status of trial NCT06645847?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-02-05. Estimated completion is 2028-04-01.

What conditions does trial NCT06645847 study?

This clinical trial studies the following conditions: Aging, Frail Elderly, Immune Function, Muscle Function.

What interventions are being tested in trial NCT06645847?

The interventions under investigation include: Ketone ester (OTHER), Placebo Comparator: Non-ketone placebo (OTHER).

Who is sponsoring clinical trial NCT06645847?

This trial is sponsored by Buck Institute for Research on Aging, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06645847 being conducted?

This trial has 3 study locations across California, Connecticut, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06645847's enrollment target sits among peer trials

180 56th of 262 higher than 207 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06645847, the US trial registry maintained by the National Library of Medicine. NCT06645847 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.